Pfizer - Yahoo Search Results

- The Pfizer Vaccine May Be Less Effective If You Have This Common Condition
  Best Life via Yahoo News· 3 days ago
  According to a new study, the Pfizer vaccine may be less effective in people with one common...
- Pfizer vaccine ‘dramatically reduces’ Covid transmission risk after one dose, study shows
  The Independent via Yahoo News· 7 days ago
  A single dose of Pfizer-BioNTech’s coronavirus vaccine cuts the number of asymptomatic infections...
- J&J, Pfizer or Moderna: Is it ethical to go vaccine ‘shopping’?
  NJ.com· 5 hours ago
  The questions have already started popping up in New Jersey social media groups for people trying to...
- Pfizer Plant Helping Boost Vaccines Has Repeat Quality Offenses
  Bloomberg· 4 hours ago
  The factory that Pfizer Inc. plans to use to boost production of its Covid-19 vaccine for the...
- Pfizer Inc. stock outperforms competitors despite losses on the day
  Market Watch· 4 hours ago
  Shares of Pfizer Inc. slid 0.55% to $34.20 Thursday, on what proved to be an all-around grim trading...
- 3 Reasons to Buy Pfizer and 1 Reason to Sell | The Motley Fool
  The Motley Fool· 5 days ago
  What should you do with Pfizer (NYSE:PFE)? It's possible that a light will click on for investors,...
- FDA: Pfizer-BioNTech Vaccine Doesnt Need Ultra-Cold Freezer Storage
  Time Magazine· 7 days ago
  When Pfizer-BioNTech’s vaccine became the first authorized for use in the U.S., the good news came...
- Could Coronavirus Variants Boost Pfizer's Vaccine Sales By 50%? | The Motley Fool
  The Motley Fool· 3 days ago
  Fifteen billion dollars: That's how much Pfizer (NYSE:PFE) projected last month in its Q4 update...
- Pfizer and Oxford Covid vaccines 'working better than we could have hoped'
  The Telegraph via Yahoo News· 2 days ago
  The Pfizer and Oxford vaccines are "working better than we could have hoped" and offering around 80...
- Where Will Pfizer Be in 1 Year? | The Motley Fool
  The Motley Fool· 3 days ago
  For the company, though, 2020 was about transformation. Management is hoping to reestablish Pfizer as a scientific trailblazer after shedding slow-growth...